Teva Pharmaceuticals (NASDAQ: TEVA) and its partner Sanofi (NASDAQ: SNY) have announced groundbreaking results from clinical ...

The FDA has started a review of MSD's respiratory syncytial virus (RSV) antibody clesrovimab, with a verdict due in the ...

The parents of seven-year-old Gungun pseudonym finally saw a light at the end of the tunnel when they heard that a foreign medicine they craved for ...